Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BJ-001 |
Synonyms | |
Therapy Description |
BJ-001 is IL-15 protein that targets integrin, which has potential antitumor activity (AACR; Mol Cancer Ther 2019;18(12 Suppl):Abs. nr LB-A21). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BJ-001 | BJ001|BJ 001 | BJ-001 is IL-15 protein that targets integrin, which has potential antitumor activity (AACR; Mol Cancer Ther 2019;18(12 Suppl):Abs. nr LB-A21). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04294576 | Phase I | BJ-001 + Pembrolizumab BJ-001 | Safety Study of BJ-001, and IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors (FIH) | Active, not recruiting | USA | 0 |